Jason Gerberry
Stock Analyst at Bank of America Securities
(4.87)
# 352
Out of 5,119 analysts
894
Total ratings
56.2%
Success rate
16.3%
Average return
Main Sectors:
Stocks Rated by Jason Gerberry
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AMPH Amphastar Pharmaceuticals | Reiterated: Sell | $20 → $23 | $28.49 | -19.27% | 18 | Nov 6, 2026 | |
| LLY Eli Lilly and Company | Reiterated: Buy | $1,497 → $1,557 | $1,354.00 | +14.99% | 23 | Nov 5, 2026 | |
| MLYS Mineralys Therapeutics | Reiterated: Buy | n/a | $15.33 | - | 5 | Nov 5, 2026 | |
| PCVX Vaxcyte | Reiterated: Buy | n/a | $63.89 | - | 34 | Nov 5, 2026 | |
| ALKS Alkermes | Reiterated: Sell | n/a | $45.90 | - | 45 | Nov 4, 2026 | |
| OCS Oculis Holding AG | Reiterated: Buy | n/a | $7.49 | - | 21 | Nov 4, 2026 | |
| PFE Pfizer | Reiterated: Hold | n/a | $29.39 | - | 15 | Nov 4, 2026 | |
| TARS Tarsus Pharmaceuticals | Reiterated: Buy | n/a | $68.60 | - | 23 | Nov 4, 2026 | |
| UTHR United Therapeutics | Reiterated: Hold | $559 → $650 | $562.02 | +15.65% | 22 | Nov 4, 2026 | |
| TLV: TEVA Teva Pharmaceutical Industries Limited | Reiterated: Buy | ILA 13,562 → ILA 15,139 | ILA 13,300 | +13.82% | 3 | Nov 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $276 → $264 | $132.37 | +99.44% | 32 | Nov 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $86 → $83 | $56.03 | +48.13% | 18 | Nov 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $313 | $234.76 | +33.33% | 76 | Nov 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $305 → $319 | $291.31 | +9.51% | 21 | Oct 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $7 → $4 | $3.50 | +14.29% | 14 | Oct 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $163 → $165 | $146.73 | +12.45% | 26 | Oct 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $66 → $67 | $62.14 | +7.82% | 17 | Oct 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $282 → $275 | $276.22 | -0.44% | 16 | Oct 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $38 → $42 | $44.40 | -5.41% | 23 | Oct 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $7 | $4.86 | +44.03% | 2 | Oct 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $41 | $15.10 | +171.52% | 2 | Oct 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $100 | $58.16 | +71.94% | 24 | Oct 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 | $0.9298 | +2,481.20% | 16 | Oct 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $30 | $33.11 | -9.39% | 18 | Oct 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $16 | $19.91 | -19.64% | 43 | Oct 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $77 | $39.17 | +96.58% | 18 | Oct 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $41 | $69.57 | -41.07% | 38 | Oct 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $91 | $39.42 | +130.85% | 50 | Oct 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $63 | $67.30 | -6.39% | 11 | Oct 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 → $39 | $29.50 | +32.20% | 5 | Aug 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $32 → $43 | $30.53 | +40.85% | 18 | May 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $7.06 | $11.56 | -38.96% | 20 | Feb 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | n/a | $13.87 | - | 15 | Feb 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $1 | $1.14 | -12.28% | 11 | Jan 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $10 | $14.48 | -30.94% | 13 | Nov 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | n/a | $29.62 | n/a | 1 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $25 → $28 | $33.45 | n/a | 18 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 | $18.60 | n/a | 18 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.77 | n/a | 7 | Oct 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.04 | n/a | 6 | Sep 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $4 → $3.5 | $0.9578 | n/a | 7 | Aug 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $4 → $2 | $3.73 | n/a | 10 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $5 → $1 | $0.626 | n/a | 4 | Jan 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $26 → $10 | $3.19 | n/a | 2 | Jul 15, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $32 | $15.60 | n/a | 1 | Mar 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $110 | $155.94 | n/a | 1 | Nov 13, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 → $6 | $0.0001 | n/a | 3 | Aug 20, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $148.75 | n/a | 2 | Jun 28, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $9 | $1.03 | n/a | 1 | Oct 16, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 → $18 | $2.88 | n/a | 7 | Nov 20, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $34 | $0.293 | n/a | 13 | Nov 15, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $59 → $37 | $36.43 | n/a | 7 | Nov 2, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $110 → $81 | $15.85 | n/a | 9 | Aug 10, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $33 → $24 | $20.14 | n/a | 7 | Aug 9, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $40.31 | n/a | 1 | Aug 8, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $10 → $14 | $4.39 | n/a | 9 | Aug 5, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $70 | $164.63 | n/a | 1 | Jul 13, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.0002 | n/a | 3 | Jan 19, 2016 |
Amphastar Pharmaceuticals
Nov 6, 2026
Reiterated: Sell
Price Target: $20 → $23
Current: $28.49
Upside: -19.27%
Eli Lilly and Company
Nov 5, 2026
Reiterated: Buy
Price Target: $1,497 → $1,557
Current: $1,354.00
Upside: +14.99%
Mineralys Therapeutics
Nov 5, 2026
Reiterated: Buy
Price Target: n/a
Current: $15.33
Upside: -
Vaxcyte
Nov 5, 2026
Reiterated: Buy
Price Target: n/a
Current: $63.89
Upside: -
Alkermes
Nov 4, 2026
Reiterated: Sell
Price Target: n/a
Current: $45.90
Upside: -
Oculis Holding AG
Nov 4, 2026
Reiterated: Buy
Price Target: n/a
Current: $7.49
Upside: -
Pfizer
Nov 4, 2026
Reiterated: Hold
Price Target: n/a
Current: $29.39
Upside: -
Tarsus Pharmaceuticals
Nov 4, 2026
Reiterated: Buy
Price Target: n/a
Current: $68.60
Upside: -
United Therapeutics
Nov 4, 2026
Reiterated: Hold
Price Target: $559 → $650
Current: $562.02
Upside: +15.65%
Teva Pharmaceutical Industries Limited
Nov 3, 2026
Reiterated: Buy
Price Target: ILA 13,562 → ILA 15,139
Current: ILA 13,300
Upside: +13.82%
Nov 2, 2026
Reiterated: Buy
Price Target: $276 → $264
Current: $132.37
Upside: +99.44%
Nov 2, 2026
Reiterated: Buy
Price Target: $86 → $83
Current: $56.03
Upside: +48.13%
Nov 2, 2026
Reiterated: Buy
Price Target: $313
Current: $234.76
Upside: +33.33%
Oct 30, 2026
Reiterated: Buy
Price Target: $305 → $319
Current: $291.31
Upside: +9.51%
Oct 30, 2026
Reiterated: Hold
Price Target: $7 → $4
Current: $3.50
Upside: +14.29%
Oct 30, 2026
Reiterated: Buy
Price Target: $163 → $165
Current: $146.73
Upside: +12.45%
Oct 29, 2026
Reiterated: Buy
Price Target: $66 → $67
Current: $62.14
Upside: +7.82%
Oct 14, 2026
Reiterated: Hold
Price Target: $282 → $275
Current: $276.22
Upside: -0.44%
Oct 14, 2026
Reiterated: Hold
Price Target: $38 → $42
Current: $44.40
Upside: -5.41%
Oct 12, 2026
Rated: Buy
Price Target: $7
Current: $4.86
Upside: +44.03%
Oct 12, 2026
Reiterated: Buy
Price Target: $41
Current: $15.10
Upside: +171.52%
Oct 12, 2026
Reiterated: Buy
Price Target: $100
Current: $58.16
Upside: +71.94%
Oct 12, 2026
Reiterated: Buy
Price Target: $24
Current: $0.9298
Upside: +2,481.20%
Oct 12, 2026
Reiterated: Sell
Price Target: $30
Current: $33.11
Upside: -9.39%
Oct 12, 2026
Reiterated: Sell
Price Target: $16
Current: $19.91
Upside: -19.64%
Oct 12, 2026
Reiterated: Buy
Price Target: $77
Current: $39.17
Upside: +96.58%
Oct 9, 2026
Reiterated: Sell
Price Target: $41
Current: $69.57
Upside: -41.07%
Oct 9, 2026
Reiterated: Buy
Price Target: $91
Current: $39.42
Upside: +130.85%
Oct 9, 2026
Reiterated: Buy
Price Target: $63
Current: $67.30
Upside: -6.39%
Aug 18, 2026
Reiterated: Buy
Price Target: $30 → $39
Current: $29.50
Upside: +32.20%
May 21, 2026
Reiterated: Buy
Price Target: $32 → $43
Current: $30.53
Upside: +40.85%
Feb 18, 2026
Reiterated: Sell
Price Target: $7.06
Current: $11.56
Upside: -38.96%
Feb 13, 2026
Reiterated: Sell
Price Target: n/a
Current: $13.87
Upside: -
Jan 12, 2026
Reiterated: Sell
Price Target: $1
Current: $1.14
Upside: -12.28%
Nov 10, 2025
Reiterated: Hold
Price Target: $10
Current: $14.48
Upside: -30.94%
Nov 7, 2025
Reiterated: Sell
Price Target: n/a
Current: $29.62
Upside: n/a
Nov 6, 2025
Reiterated: Sell
Price Target: $25 → $28
Current: $33.45
Upside: n/a
Nov 6, 2025
Reiterated: Buy
Price Target: $15
Current: $18.60
Upside: n/a
Oct 30, 2023
Rated: Hold
Price Target: n/a
Current: $0.77
Upside: n/a
Sep 28, 2023
Rated: Hold
Price Target: n/a
Current: $1.04
Upside: n/a
Aug 9, 2023
Reiterated: Sell
Price Target: $4 → $3.5
Current: $0.9578
Upside: n/a
Aug 8, 2023
Downgraded: Sell
Price Target: $4 → $2
Current: $3.73
Upside: n/a
Jan 5, 2023
Reiterated: Sell
Price Target: $5 → $1
Current: $0.626
Upside: n/a
Jul 15, 2020
Downgraded: Hold
Price Target: $26 → $10
Current: $3.19
Upside: n/a
Mar 11, 2020
Initiated Coverage: Buy
Price Target: $32
Current: $15.60
Upside: n/a
Nov 13, 2019
Initiated Coverage: Buy
Price Target: $110
Current: $155.94
Upside: n/a
Aug 20, 2019
Reiterated: Buy
Price Target: $5 → $6
Current: $0.0001
Upside: n/a
Jun 28, 2019
Downgraded: Sell
Price Target: n/a
Current: $148.75
Upside: n/a
Oct 16, 2018
Downgraded: Sell
Price Target: $9
Current: $1.03
Upside: n/a
Nov 20, 2016
Reiterated: Buy
Price Target: $14 → $18
Current: $2.88
Upside: n/a
Nov 15, 2016
Reiterated: Buy
Price Target: $34
Current: $0.293
Upside: n/a
Nov 2, 2016
Reiterated: Hold
Price Target: $59 → $37
Current: $36.43
Upside: n/a
Aug 10, 2016
Reiterated: Hold
Price Target: $110 → $81
Current: $15.85
Upside: n/a
Aug 9, 2016
Reiterated: Hold
Price Target: $33 → $24
Current: $20.14
Upside: n/a
Aug 8, 2016
Reiterated: Hold
Price Target: n/a
Current: $40.31
Upside: n/a
Aug 5, 2016
Reiterated: Hold
Price Target: $10 → $14
Current: $4.39
Upside: n/a
Jul 13, 2016
Reiterated: Buy
Price Target: $70
Current: $164.63
Upside: n/a
Jan 19, 2016
Downgraded: Hold
Price Target: n/a
Current: $0.0002
Upside: n/a